:: Altroz - News Magazine HTML Template ::

Language:

Spikevax News

Moderna Faces $1 Billion Net Loss in Q1 2025 Amid Declining COVID-19 Vaccine Sales

James Carter 01 May, 2025

Moderna reports a $1 billion net loss in Q1 2025 due to decreased COVID-19 vaccine sales, with Spikevax® generating $84 million. CEO Stephane Bancel remains optimistic about future...

Spikevax News

Moderna Faces $1 Billion Net Loss in Q1 2025 Amid Declining COVID-19 Vaccine Sales

Popular News

Trump Considers Imposing 25% Tariffs on Mexico and Canada to Combat Fentanyl Crisis

German Companies Eye Expansion in Tamil Nadu: A Promising Partnership

South Korea Advances with 'K-Chips Act' and Energy Laws to Strengthen Semiconductor and Power Sectors

Escalating U.S.-EU Trade Tensions: Trump Stands Firm on Tariffs Amid Global Backlash

Meta Platforms Inc. Announces Massive Layoffs: What Employees Need to Know

Salesforce Q3 Revenue Surges 8% to $9.44B, Beating Analysts' Expectations

US Stock Market Soars Following Federal Reserve's Decision to Hold Rates Steady

Indian Bank Fined by Central Bank of Sri Lanka for Non-Compliance

Newsletter

Subscribe Newsletter!

Privacy Policy

Terms & Conditions

Contact Us